首都医科大学学报 ›› 2003, Vol. 24 ›› Issue (3): 310-313.

• 论著·临床研究 • 上一篇    下一篇

前列腺素E1应用于肾移植受者的实验及临床观察

刘庆军, 徐秀红, 张玉海   

  1. 首都医科大学附属北京友谊医院泌尿外科
  • 收稿日期:2002-09-12 修回日期:1900-01-01 出版日期:2003-07-15 发布日期:2003-07-15

Clinical Observation of PGE1 Used in Renal Recipients

Liu Qingjun, Xu Xiuhong, Zhang Yuhai   

  1. Department of Urology, Beijing Friendship Hospital, Affiliate of Capital University of Medical Sciences
  • Received:2002-09-12 Revised:1900-01-01 Online:2003-07-15 Published:2003-07-15

摘要: 为探讨前列腺素E1(PGE1)应用于肾移植患者的免疫抑制机制,及其对肾移植受者的影响,进行:1)基础实验:选取正常人16例及尿毒症患者10例,取其外周血淋巴细胞,体外用植物血凝素(PHA)刺激,检测PGE1对淋巴细胞增生的抑制能力。2)临床观察:对14例(A组)肾移植受者术后持续应用PGE120μg/d,与同期11例(B组)未使用PGE1的肾移植受者相比,比较2组术后血肌酐、尿素氮、血流变学以及2组急性排斥反应的发生率。结果:体外实验显示PGE1可以抑制PHA刺激的T淋巴细胞增生;术后5dA组的尿量比B组明显增多(P<0.05);术后14dA组的肌酐、尿素氮比B组明显减少(P<0.05);术后A组的血黏度、红细胞刚性指数、血小板聚集率等血流变学参数明显好于B组(P<0.05);术后A组的急性排斥反应发生率(14.3%)低于B组(36.4%)。提示:PGE1在体外可以抑制PHA刺激的T淋巴细胞增生,且呈剂量依赖关系;肾移植患者术后应用PGE1可以明显改善移植肾功能,对降低急性排斥反应的发生率可能有一定的作用。

关键词: 前列腺素E1, 肾移植, 实验, 临床

Abstract: To investigate the immunosuppressive mechanism of lipo-PGE1 and to observe the changes in kidney recipient caused by lipo-PGE1. Methods: 1) Lipo-PGE 1 was examined for its in vitro suppressive effects on blastogenesis of mitogen-stimulated PBLobtained from 6 healthy volunteer and 10 chronic renal failure (CRF) candidates for renal transplantation. 2) Fourteen patients receiving renal transplantation in the experimental group were treated with lipo-PGE1, Csa, Aza and prednisone for fourteen days and eleven patients under the same conditions were only treated with Csa, Aza and prednisone. Blood creatine, ureanitrogen, hemorrheology and incidents of acute rejection were examined. Results: Urine volume was significantly higher in group A than that in group B five days after operation. On the contrary, blood creatine and ureanitrogen were significantly lower in group Athan in group Bseven days after operation. Erythrocyte rigid index, rate of platelet aggregation and blood viscosity were much better in group A than in group B. Incidents of acute rejection were higher in group A than in group B. Conclusion: The findings suggest that the addition of lipo-PGE1 to renal recipients significantly improve graft function and reduce the incidents of acute rejection. In vitro lipo-PGE1 can inhibite the proliferation of T-lymphocyte stimulate by PHA.

Key words: PGE1, kidney transplantation, experiment, clinical

中图分类号: